secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker PURE CIK 0001006028
other material confidence high sentiment neutral materiality 0.60

Pure Bioscience raises $1.0M in private placement at $0.0553/share; directors invest

PURE BIOSCIENCE, INC.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

PURE BIOSCIENCE, INC. issued 18,131,096 shares of common stock to accredited investors for $0.0553 per share.

Security
common stock
Shares
18,131,096 shares
Purchaser
accredited investors
Consideration
$0.0553 per share
Exact text from the filing
The Company raised $1.0 million in the Closing and issued an aggregate of 18,131,096 shares (collectively, the “Shares”) of the Company’s common stock at a purchase price of $0.0553 per share.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

PURE BIOSCIENCE, INC. entered into Securities Purchase Agreement with certain accredited investors valued at $1.0 million (effective 2026-04-30).

Action
entry
Agreement
equity purchase
Counterparty
certain accredited investors
Value
$1.0 million
Effective
2026-04-30
Exact text from the filing
ssued in the Private Placement Financing were issued pursuant to a Securities Purchase Agreement (the “Securities Purchase Agreement”) entered into with the Investors.
View on SEC.gov

Browse all equity issuances →

PURE BIOSCIENCE, INC. filing history →

Source: SEC EDGAR
accession 0001493152-26-021329
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.